Radicava ORS Side Effects
Generic name: edaravone
Medically reviewed by Drugs.com. Last updated on May 22, 2024.
Note: This document contains side effect information about edaravone. Some dosage forms listed on this page may not apply to the brand name Radicava ORS.
Applies to edaravone: oral suspension. Other dosage forms:
Serious side effects of Radicava ORS
Along with its needed effects, edaravone (the active ingredient contained in Radicava ORS) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking edaravone:
More common
- Blistering, crusting, irritation, itching, or reddening of the skin
- blue lips, fingernails, or skin
- confusion
- difficult or trouble breathing
- dizziness
- fast heartbeat
- headache
- irregular, fast or slow, or shallow breathing
- swelling
- trouble in walking
- unusual bruising
- weakness
Less common
- Itching in the genital or other skin areas
- scaling
- sugar in the urine
Incidence not known
- Chest tightness
- cough
- difficulty swallowing
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- skin itching, rash, or redness
- swelling of the face, throat, or tongue
- unusual tiredness or weakness
For Healthcare Professionals
Applies to edaravone: intravenous solution, oral suspension.
General
The most common adverse reactions are contusion, gait disturbance, and headache.[Ref]
Dermatologic
Very common (10% or more): Contusion (up to 15%)
Common (1% to 10%): Dermatitis, eczema, tinea infection, rash, erythema[Ref]
Gastrointestinal
Common (1% to 10%): Nausea[Ref]
Hypersensitivity
Postmarketing reports: Hypersensitivity reactions, anaphylaxis[Ref]
Musculoskeletal
Common (1% to 10%): Ligament sprain[Ref]
Nervous system
Very common (10% or more): Gait disturbance (up to 13%), headache (up to 10%)[Ref]
Other
Common (1% to 10%): Excoriation[Ref]
Renal
Common (1% to 10%): Glycosuria[Ref]
Respiratory
Common (1% to 10%): Respiratory failure/respiratory disorder/hypoxia, upper respiratory tract inflammation, upper respiratory tract infection[Ref]
More about Radicava ORS (edaravone)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous central nervous system agents
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
References
1. (2023) "Product Information. Radicava (edaravone)." Teva Pharma Australia Pty Ltd
2. (2022) "Product Information. Radicava ORS (edaravone)." Mitsubishi Tanabe Pharma America (formerly MT Pharma America), SUPPL-12
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.